PortfoliosLab logo
NVS vs. PG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVS and PG is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

NVS vs. PG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NVS) and The Procter & Gamble Company (PG). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%NovemberDecember2025FebruaryMarchApril
2.06%
3.30%
NVS
PG

Key characteristics

Sharpe Ratio

NVS:

1.29

PG:

0.59

Sortino Ratio

NVS:

1.82

PG:

0.87

Omega Ratio

NVS:

1.24

PG:

1.12

Calmar Ratio

NVS:

1.16

PG:

0.85

Martin Ratio

NVS:

2.57

PG:

2.33

Ulcer Index

NVS:

9.02%

PG:

4.29%

Daily Std Dev

NVS:

17.92%

PG:

17.04%

Max Drawdown

NVS:

-41.72%

PG:

-54.23%

Current Drawdown

NVS:

-3.80%

PG:

-3.48%

Fundamentals

Market Cap

NVS:

$221.72B

PG:

$404.23B

EPS

NVS:

$5.87

PG:

$6.29

PE Ratio

NVS:

19.12

PG:

27.41

PEG Ratio

NVS:

1.31

PG:

3.39

Total Revenue (TTM)

NVS:

$39.24B

PG:

$64.15B

Gross Profit (TTM)

NVS:

$29.47B

PG:

$32.96B

EBITDA (TTM)

NVS:

$16.05B

PG:

$17.75B

Returns By Period

In the year-to-date period, NVS achieves a 19.52% return, which is significantly higher than PG's 3.45% return. Over the past 10 years, NVS has underperformed PG with an annualized return of 7.10%, while PG has yielded a comparatively higher 10.66% annualized return.


NVS

YTD

19.52%

1M

4.38%

6M

2.23%

1Y

23.24%

5Y*

11.72%

10Y*

7.10%

PG

YTD

3.45%

1M

-0.46%

6M

2.55%

1Y

13.12%

5Y*

11.17%

10Y*

10.66%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NVS vs. PG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVS
The Risk-Adjusted Performance Rank of NVS is 8484
Overall Rank
The Sharpe Ratio Rank of NVS is 8989
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 8383
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 8383
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 8787
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 7878
Martin Ratio Rank

PG
The Risk-Adjusted Performance Rank of PG is 7171
Overall Rank
The Sharpe Ratio Rank of PG is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of PG is 6262
Sortino Ratio Rank
The Omega Ratio Rank of PG is 6363
Omega Ratio Rank
The Calmar Ratio Rank of PG is 8181
Calmar Ratio Rank
The Martin Ratio Rank of PG is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NVS vs. PG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for NVS, currently valued at 1.29, compared to the broader market-2.00-1.000.001.002.003.00
NVS: 1.29
PG: 0.59
The chart of Sortino ratio for NVS, currently valued at 1.82, compared to the broader market-6.00-4.00-2.000.002.004.00
NVS: 1.82
PG: 0.87
The chart of Omega ratio for NVS, currently valued at 1.24, compared to the broader market0.501.001.502.00
NVS: 1.24
PG: 1.12
The chart of Calmar ratio for NVS, currently valued at 1.16, compared to the broader market0.001.002.003.004.005.00
NVS: 1.16
PG: 0.85
The chart of Martin ratio for NVS, currently valued at 2.57, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
NVS: 2.57
PG: 2.33

The current NVS Sharpe Ratio is 1.29, which is higher than the PG Sharpe Ratio of 0.59. The chart below compares the historical Sharpe Ratios of NVS and PG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50NovemberDecember2025FebruaryMarchApril
1.29
0.59
NVS
PG

Dividends

NVS vs. PG - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.45%, more than PG's 2.34% yield.


TTM20242023202220212020201920182017201620152014
NVS
Novartis AG
3.45%3.88%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%
PG
The Procter & Gamble Company
2.34%2.36%2.55%2.38%2.08%2.24%2.37%3.09%2.98%3.18%3.32%2.78%

Drawdowns

NVS vs. PG - Drawdown Comparison

The maximum NVS drawdown since its inception was -41.72%, smaller than the maximum PG drawdown of -54.23%. Use the drawdown chart below to compare losses from any high point for NVS and PG. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-3.80%
-3.48%
NVS
PG

Volatility

NVS vs. PG - Volatility Comparison

Novartis AG (NVS) has a higher volatility of 6.66% compared to The Procter & Gamble Company (PG) at 5.67%. This indicates that NVS's price experiences larger fluctuations and is considered to be riskier than PG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%NovemberDecember2025FebruaryMarchApril
6.66%
5.67%
NVS
PG

Financials

NVS vs. PG - Financials Comparison

This section allows you to compare key financial metrics between Novartis AG and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items